Study of the Diagnostic Accuracy of the Neurodynamic Tests in Patients With Lumbar Radiculopathy
Launched by UNIVERSIDAD DE ZARAGOZA · Nov 23, 2022
Trial Information
Current as of July 06, 2025
Unknown status
Keywords
ClinConnect Summary
Background and justification Background Lumbar radiculopathy is a relevant cause of disability and morbidity and may constitute between 23 and 57% of the cases of patients with low back pain and represents an important expense due to the sick leave and health care that may be required. It is a pathological process that can affect different lumbar roots and can cause radiating symptoms that manifest in the territory of the lower limb that includes this root. Some studies estimate the prevalence in the general population to be between 1.6 and 13.4%, with the predominant age range being betwee...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being between 18 and 75 years of age.
- • Having symptoms compatible with lumbar radiculopathy at the time of the study. Intermittent or constant pain in the lumbar area or radiating to a distal extremity, to the gluteal fold; or distribution of pain in all or part of the dermatomic area of one or two adjacent lumbosacral nerve roots (L3-S2 segments).
- • Have undergone or are awaiting MRI of the lumbar region.
- • Have been referred for an electrophysiological study of the sciatic nerve or its branches.
- • Have sufficient comprehension and communication skills to be able to communicate their symptoms and their characteristics.
- • Accept and give their consent to participate voluntarily in the study and provide their clinical data anonymously.
- Exclusion Criteria:
- • Having radiological tests with a diagnosis of spondylolysis and/or spondylolisthesis in the lumbar region.
- • Having been diagnosed with diabetes, thyroid dysfunction, rheumatoid arthritis, heart and/or lung disease, alcoholism, HIV+, herpes zoster infection, multiple sclerosis, hereditary neuropathy or any known neurodegenerative disease and/or pregnancy.
- • Have undergone lumbar surgery and/or transforaminal epidural steroid injection within the previous 12 months.
- • Have received physiotherapeutic neurodynamic treatment.
- • Have suffered a fracture of any vertebrae of the spine.
- • Have been diagnosed with other compressive causes or causes that produce irritation of the lumbar roots or stenosis of the spinal canal.
- • Be unable or have contraindications to adopt the supine decubitus and/or seated position with lumbar, dorsal and cervical flexion or to maintain the position for the duration of the tests.
- • Present any physical contraindication (red flags) such as neoplastic processes, serious infections; or psychological contraindication (yellow flags) such as psychiatric pathologies that could influence the state of the subjects or the results of the study.
- • That the MRI is performed more than 12 months after the clinical examination.
- • Failure to complete all the assessment phases of the study.
About Universidad De Zaragoza
The Universidad de Zaragoza, a prestigious institution in Spain, is dedicated to advancing scientific research and innovation through its clinical trial sponsorship. With a strong emphasis on interdisciplinary collaboration, the university fosters a robust environment for conducting high-quality clinical studies that aim to improve healthcare outcomes. Leveraging its extensive academic resources and expertise across various medical fields, the Universidad de Zaragoza is committed to ethical research practices and the promotion of evidence-based medicine, contributing to the advancement of knowledge and the betterment of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zaragoza, Aragon, Spain
Patients applied
Trial Officials
Elena Bueno-Gracia, PT PhD
Study Director
Universidad Zaragoza
Santos Caudevilla-Polo, PT PhD
Study Director
Universidad Zaragoza
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials